Page last updated: 2024-09-04

caseins and eflucimibe

caseins has been researched along with eflucimibe in 2 studies

Compound Research Comparison

Studies (caseins)	Trials (caseins)	Recent Studies (post-2010) (caseins)	Studies (eflucimibe)	Trials (eflucimibe)	Recent Studies (post-2010) (eflucimibe)
16,863	561	4,170	18	0	3

Protein Interaction Comparison

Protein	Taxonomy	caseins (IC50)	eflucimibe (IC50)
Sterol O-acyltransferase 2	Homo sapiens (human)		0.11
Sterol O-acyltransferase 1	Homo sapiens (human)		0.039

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Autin, JM; Bruniquel, F; Colpaert, FC; Degryse, AD; Delhon, A; Junquero, D; N'Guyen, X; Patoiseau, JF	1
Bruniquel, F; Degryse, AD; Delhon, A; Fauré, P; Junquéro, D; N'Guyen, X; Pomiès, JP; Rival, Y	1

Other Studies

2 other study(ies) available for caseins and eflucimibe

Article	Year
F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. Atherosclerosis, 2001, Volume: 155, Issue:1 Topics: Adrenal Glands; Anilides; Animals; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Atorvastatin; Caseins; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Male; Pyrroles; Rabbits; Sterol O-Acyltransferase	2001
Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits. Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2 Topics: Anilides; Animals; Anticholesteremic Agents; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Caseins; Catheterization; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; Hyperplasia; Immunohistochemistry; Male; Rabbits; Sterol O-Acyltransferase; Triglycerides; Tunica Intima	2002

Article

Year

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet.

Atherosclerosis, 2001, Volume: 155, Issue:1

Topics: Adrenal Glands; Anilides; Animals; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Atorvastatin; Caseins; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Male; Pyrroles; Rabbits; Sterol O-Acyltransferase

2001

Anti-atherosclerotic properties of the acyl-coenzyme A:cholesterol acyltransferase inhibitor F 12511 in casein-fed New Zealand rabbits.

Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:2

Topics: Anilides; Animals; Anticholesteremic Agents; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Caseins; Catheterization; Cholesterol; Diet, Atherogenic; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Hypercholesterolemia; Hyperplasia; Immunohistochemistry; Male; Rabbits; Sterol O-Acyltransferase; Triglycerides; Tunica Intima

2002